DDInter248 DDInter688
Bumetanide is a sulfamyl diuretic.
Etelcalcetide is a calcimimetic drug for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis. Etelcalcetide was approved (trade name Parsabiv) for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis in February, 2017.
Bumetanide {u} (Compound) treats {v} (Disease) hypertension
hypertension {u} (Disease) is treated by {v} (Compound) Torasemide
Torasemide {u} may lead to a major life threatening interaction when taken with {v} Etelcalcetide
Bumetanide {u} (Compound) binds {v} (Gene) SLC12A1
SLC12A1 {u} (Gene) is bound by {v} (Compound) Torasemide
Torasemide {u} may lead to a major life threatening interaction when taken with {v} Etelcalcetide
Bumetanide {u} (Compound) palliates {v} (Disease) chronic kidney failure
chronic kidney failure {u} (Disease) is palliated by {v} (Compound) Torasemide
Torasemide {u} may lead to a major life threatening interaction when taken with {v} Etelcalcetide
Bumetanide {u} (Compound) is included by {v} (Pharmacologic Class) Increased Diuresis at Loop of Henle
Increased Diuresis at Loop of Henle {u} (Pharmacologic Class) includes {v} (Compound) Torasemide
Torasemide {u} may lead to a major life threatening interaction when taken with {v} Etelcalcetide
Bumetanide {u} (Compound) causes {v} (Side Effect) Rash
Rash {u} (Side Effect) is caused by {v} (Compound) Torasemide
Torasemide {u} may lead to a major life threatening interaction when taken with {v} Etelcalcetide
Bumetanide {u} (Compound) resembles {v} (Compound) Indapamide
Indapamide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Amifostine
Amifostine {u} may lead to a major life threatening interaction when taken with {v} Etelcalcetide
Bumetanide (Compound) treats hypertension (Disease) and hypertension (Disease) is treated by Torasemide (Compound) and Torasemide may lead to a major life threatening interaction when taken with Etelcalcetide
Bumetanide (Compound) binds SLC12A1 (Gene) and SLC12A1 (Gene) is bound by Torasemide (Compound) and Torasemide may lead to a major life threatening interaction when taken with Etelcalcetide
Bumetanide (Compound) palliates chronic kidney failure (Disease) and chronic kidney failure (Disease) is palliated by Torasemide (Compound) and Torasemide may lead to a major life threatening interaction when taken with Etelcalcetide
Bumetanide (Compound) is included by Increased Diuresis at Loop of Henle (Pharmacologic Class) and Increased Diuresis at Loop of Henle (Pharmacologic Class) includes Torasemide (Compound) and Torasemide may lead to a major life threatening interaction when taken with Etelcalcetide
Bumetanide (Compound) causes Rash (Side Effect) and Rash (Side Effect) is caused by Torasemide (Compound) and Torasemide may lead to a major life threatening interaction when taken with Etelcalcetide
Bumetanide (Compound) resembles Indapamide (Compound) and Indapamide may cause a moderate interaction that could exacerbate diseases when taken with Amifostine and Amifostine may lead to a major life threatening interaction when taken with Etelcalcetide